HEMEMICS Biotechnologies
Business Services · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
401 Professional Dr Ste 220, Gaithersbur...Phone Number
(240) 800-1113Website
www.hememics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About HEMEMICS Biotechnologies
Hememics Biotechnologies is a biotech company developing a first-in-class, handheld, multiplexed biosensor platform that can test antibodies, antigens and molecular targets simultaneously. The company is headquartered in Gaithersburg, Maryland.Explore more
HEMEMICS Biotechnologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HEMEMICS Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
HEMEMICS Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if HEMEMICS Biotechnologies had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at HEMEMICS Biotechnologies
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when HEMEMICS Biotechnologies launches new products
Check out if HEMEMICS Biotechnologies is spiking on competitors!
Funding: Get notified immidiatlly once HEMEMICS Biotechnologies has new funding data
Earning: See what the market has to say on HEMEMICS Biotechnologies recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if HEMEMICS Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to HEMEMICS Biotechnologies
Compare insights from companies similar to HEMEMICS Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
HEMEMICS Biotechnologies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
HEMEMICS Biotechnologies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about HEMEMICS Biotechnologies.
HEMEMICS Biotechnologies financials insights
Gather financial insights about HEMEMICS Biotechnologies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Private Equity
$2.5M
2021
Debt
$106K
2023
Angel/Seed
$2M
Debt
$500K
HEMEMICS Biotechnologies Tech Stack
A closer look at the technologies used by HEMEMICS Biotechnologies
See more technologies
Most Recent Scoops
Funding
Funding
Funding
HEMEMICS Biotechnologies has received an SBA PPP loan in the amount of $106,344 from Customers Bank resulting in the retention of 6 jobs.
Funding
Funding
HEMEMICS Biotechnologies News & Media
Hememics Biotechnologies, Inc. Announces Successful Close in $2 Million Seed 2 Financing from TEDCO and Qualified Investors to Accelerate Growth
GAITHERSBURG, Md., May 25, 2023 /PRNewswire/ -- Hememics Biotechnologies, Inc., developer of first-in-class, handheld, multiplexed biosensor platform that can test antibodies, antigens and molecular targets simultaneously, announced today the closing of a $2 million Seed 2 financing round....HEMEMICS Biotechnologies, Inc. Receives HHS Support to Develop Rapid Antigen, Antibody Diagnostic to Identify COVID-19 Infected Americans
Hememics Biotechnologies Inc., ("Hememics" or the "Company") announced that they are partnering with the Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, on the development of a rapid, Bluetooth®-connected, easy-to-use test to diagnose COVID-19 in 60 seconds or less. The test detects SARS-CoV-2 and associated antibodies from nasal swabs or whole blood, mHememics Biotechnologies Inc. Received $2.5 Million Investment from AMVI Partners
ROCKVILLE, Md., Dec. 11, 2019 /PRNewswire/ -- Hememics Biotechnologies Inc., ("Hememics" or the "Company") announced that AMVI Partners, a consortium of high net worth Vietnamese investors, has invested $2.5 million into Hememics. The company will use the funds to initiate clinical...Hememics Biotechnologies Inks $2.5M Investment
ROCKVILLE, MD, Hememics Biotechnologies announced that AMVI Partners has invested $2.5 million.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding HEMEMICS Biotechnologies
Sign Up For FreeTo access detailed company insights
Hememics Biotechnologies is a biotech company developing a first-in-class, handheld, multiplexed biosensor platform that can test antibodies, antigens and molecular targets simultaneously. The company is headquartered in Gaithersburg, Maryland.... Read More
